Close Menu

microarrays

NEW YORK (GenomeWeb) – Illumina reported after the close of the market Monday that its third quarter revenues climbed 35 percent year over year, as the firm easily beat Wall Street estimates on the top and bottom lines.

SAN DIEGO (GenomeWeb) – Ancient human samples and additional genetic analyses are giving researchers a deep look into the structure of human populations.

NEW YORK (GenomeWeb) – Affymetrix today said it has exclusively licensed technology from Peptide Groove for HLA typing of human samples.

NEW YORK (GenomeWeb) – The Centers for Medicare and Medicaid Services on Thursday published a draft local coverage determination (LCD) for GenomeDx's Decipher genomic test for men who have undergone a radical prostatectomy.

NEW YORK (GenomeWeb) — Biocept and Rosetta Genomics said this week that they will pair Biocept's circulating tumor cell isolation technology with Rosetta's microRNA analysis platforms to investigate the possibility of developing blood-based cancer diagnostics and therapeutic response assays.

Patrick Balthrop has retired as president and CEO of Luminex, and Nachum Shamir has been named as the new president and CEO, the company said this week.

NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators at Columbia and Yale Universities unveiled previously unknown risk loci for IgA nephropathy, a kidney condi

NEW YORK (GenomeWeb) — Affymetrix and Ariosa Diagnostics today announced that they have signed a multi-year agreement under which Affymetrix will supply arrays and instruments for use in Ariosa's Harmony non-invasive prenatal test.

NEW YORK (GenomeWeb) – SkylineDx and the Ribeirão Preto Medical School at the University of São Paulo on Tuesday said they have begun collaborating on a study using SkylineDx's AMLprofiler test on acute myeloid leukemia patients.

NEW YORK (GenomeWeb) — Oxford Gene Technology has launched a new microarray product that it believes will be attractive to medical research laboratories that use targeted, next-generation sequencing panels.

Pages

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.